Effect of telemedicine follow-up on ventilator-free days among older adults
Published
March 12, 2024
Paper ID
PAP-000197
Status
Published
DOI
10.65712/tmj.test000455
Advance Services
Abstract
Background: Practice around telemedicine follow-up varies widely between centres. Methods: We conducted a case series across 8 centres between 2014 and 2022. Results: Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. Conclusion: Residual confounding cannot be excluded.
References
1. Farouk L, Haddad N, et al. Machine-learning triage and acute kidney injury. Lancet. 2009;25(4):455-988.
2. Nasser V, Larsen C, et al. A sepsis alert system and surgical site infection. Eur Heart J. 2014;43(1):336-1615.
3. Okafor N, Moreau R, et al. Early mobilisation and emergency department revisits. BMJ. 2008;142(5):343-1586.
4. Kim P, Rahman R, et al. Pharmacist-led medication review and 30-day readmission. Crit Care Med. 2011;228(9):673-1597.
5. Farouk E, Lindqvist O, et al. An antibiotic stewardship programme and surgical site infection. Crit Care Med. 2022;133(7):62-1510.
6. Andersen F, Kowalski A, et al. Low-dose aspirin and time to diagnosis. Ann Intern Med. 2020;123(3):156-1616.
Introduction
The cost of ventilator-free days to health systems is substantial. Practice around telemedicine follow-up varies widely between centres. Guidelines make only a weak recommendation on telemedicine follow-up.
Practice around telemedicine follow-up varies widely between centres. ventilator-free days remains a leading cause of avoidable harm among older adults.
The cost of ventilator-free days to health systems is substantial. Earlier studies of telemedicine follow-up were small or single-centre.
Materials and Methods
The primary outcome was ventilator-free days, assessed blind to allocation. Eligible participants were older adults. We conducted a case series across 2 centres between 2019 and 2021.
Eligible participants were older adults. Analyses were adjusted for age, sex and baseline severity.
Results
Effects were consistent across prespecified subgroups. 4528 participants were included (median age 42 years). Serious adverse events were rare and similar between groups.
Effects were consistent across prespecified subgroups. ventilator-free days occurred in 10% of the intervention group versus 26% of controls. ventilator-free days occurred in 16% of the intervention group versus 29% of controls. Serious adverse events were rare and similar between groups.
| Group | n | Events | Rate % |
|---|---|---|---|
| Age < 65 | 112 | 89 | 2.6 |
| Female | 729 | 3 | 20.9 |
| Intervention | 502 | 90 | 3.9 |
| Centre B | 829 | 1 | 14.4 |
Values are n (%) unless stated otherwise.

Shown for older adults; error bars are 95% confidence intervals.

Shown for older adults; error bars are 95% confidence intervals.
ventilator-free days occurred in 13% of the intervention group versus 28% of controls. The adjusted odds ratio was 0.78 (95% CI 0.25 to 0.89).
Discussion
Strengths include the sample size and blinded outcome assessment.
Future work should test telemedicine follow-up in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Strengths include the sample size and blinded outcome assessment. These findings suggest that telemedicine follow-up is associated with better ventilator-free days in older adults. Future work should test telemedicine follow-up in a pragmatic multicentre trial.
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Future work should test telemedicine follow-up in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Conclusions
Telemedicine follow-up should be considered for older adults to improve ventilator-free days.
Appendices
Supplementary tables are available on request.